VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TDACWTranslational Development Acquisition Corp.
$1.27$22M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTDACWBalance Sheet

Translational Development Acquisition Corp. (TDACW) Balance Sheet

8Y historyFree accessUpdated daily

The balance sheet reflects a critical liquidity shortfall, evidenced by a current ratio of 0.09 and a nominal cash balance of only $24,600 as of 2026Q1.

TDACW Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'20Dec'19Dec'18Dec'17
Total Current Assets75.32K39.47K650.23K2.02K54.23K1.04K158.38K1.32M143.4K
Cash & Short-Term Investments---------
Cash Only---------
Short-Term Investments---------
Accounts Receivable---------
Days Sales Outstanding---------
Inventory---------
Days Inventory Outstanding---------
Other Current Assets00000-63.34K-74.27M63.84K0
Total Non-Current Assets183.27M181.66M174.35M0383.01K63.41K74.38M207.75M404.24K
Property, Plant & Equipment000000000
Fixed Asset Turnover---------
Goodwill009.06T000000
Intangible Assets0012.57T000000
Long-Term Investments722.85M181.66M174.35M00074.38M207.75M0
Other Non-Current Assets---------
Total Assets183.35M181.7M175M2.02K437.24K64.44K74.54M209.07M547.64K
Asset Turnover0.00x-0.01x------
Asset Growth %289360.89%3.83%8659008.31%-99.54%--99.91%-64.35%38077.12%-
Total Current Liabilities861.09K544.07K210.3K509.68K459.39K5.4K1.02M958.31K525K
Accounts Payable0162.31K16.19K1.25K0326159.38K159.51K0
Days Payables Outstanding---------
Short-Term Debt500K200K6.11T347.5K259K5.08M180K425K525K
Deferred Revenue (Current)0--------
Other Current Liabilities361.08K0-6.11T-1.25K200.34K-5.07M679.43K373.79K0
Current Ratio0.09x0.07x3.09x0.00x0.12x0.19x0.16x1.38x0.27x
Quick Ratio0.09x0.07x3.09x0.00x0.12x0.19x0.16x1.38x0.27x
Cash Conversion Cycle---------
Total Non-Current Liabilities6.04M6.04M6.04M0-500180K425.85K0
Long-Term Debt000000180K425K0
Capital Lease Obligations0--------
Deferred Tax Liabilities0--------
Other Non-Current Liabilities---------
Total Liabilities6.9M6.58M6.25M509.68K459.34K10.43K69.54M204.07M525K
Total Debt500K200K347.5K347.5K259K5.08M360K850K525K
Net Debt475.37K170.21K-90.67K345.48K256.77K-973304.54K-405.82K381.6K
Debt / Equity0.00x0.00x0.00x--0.09x0.01x0.00x23.19x
Debt / EBITDA-0.57x-----0.05x0.20x10.07x
Net Debt / EBITDA-0.54x-----0.04x-0.10x7.32x
Interest Coverage---0.14x----0.25x-0.28x-
Total Equity176.45M175.12M168.75M-507.66K-22.11K54.23M68.49M203.08M22.64K
Equity Growth %64357.36%3.77%33341.43%-2196.26%--20.82%-66.28%896832.76%-
Book Value per Share10.2310.1541.67-0.13-0.017.569.6435.280.00
Total Shareholders' Equity176.45M175.12M168.75M-507.66K-22.11K54.23M68.49M203.08M22.64K
Common Stock183.27M181.66M18.33B46646649.23K7.15K7.07K3.74K
Retained Earnings-6.82M-6.54M-5.6M-532.66K-47.11K3.13K3.93M1.4M-2.36K
Treasury Stock000000000
Accumulated OCI0016.88B000000
Minority Interest000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Imminent Liquidation and Insolvency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-Q (2026Q1)

Deteriorating Financial Position Over Time

As reported in financial statements, TDACW's balance sheet trajectory reflects a persistent erosion of liquidity, with cash reserves falling to a nominal $24,600 by 2026Q1, signaling that the entity's ability to sustain its search-phase operations is increasingly dependent on external capital injections or sponsor support.

The consistent decline in cash relative to administrative liabilities suggests that the entity is struggling to maintain its public listing status without recurring capital infusions. This trend indicates a weakening financial foundation that may force management into sub-optimal strategic decisions as the liquidation deadline approaches.

Critical Liquidity Constraints Threaten Viability

Based on the 2026Q1 data, the current ratio of 0.09 highlights a severe liquidity shortfall, as the company's cash balance of $24,600 is insufficient to cover its short-term obligations, suggesting that the entity lacks the necessary buffer to navigate even minor operational or regulatory shocks.

A current ratio well below unity implies that the company is effectively insolvent on a working capital basis, relying entirely on the potential for future sponsor loans or external financing. Investors should monitor whether the sponsor continues to provide the necessary capital to prevent a technical default or forced liquidation.

Leverage Masked by Accounting Distortions

According to recent SEC filings, the company's debt profile has shown extreme volatility, including a reported $6.1 trillion figure in 2024Q4 that appears to be a data anomaly or accounting distortion, necessitating caution when interpreting the entity's actual leverage and long-term financial obligations to its sponsor.

The erratic nature of the reported debt figures suggests that the balance sheet is heavily influenced by non-cash accounting adjustments rather than traditional credit facilities. This lack of transparency regarding actual debt obligations makes it difficult to assess the true cost of capital or the potential dilution impact on shareholders.

Hidden Risks in Asset Valuation

As indicated by the historical data, the presence of $9.1 million in goodwill during 2025, which subsequently vanished, suggests significant volatility in asset valuation that may obscure the true economic value of the entity's holdings and its underlying ability to secure a viable merger partner.

The sudden appearance and disappearance of goodwill on the balance sheet warrants further investigation, as it may reflect aggressive accounting treatments or failed acquisition attempts. This instability in asset quality undermines confidence in the company's ability to present a stable pro-forma balance sheet to potential merger targets.

TDACW — Frequently Asked Questions

Quick answers to the most common questions about buying TDACW stock.

What are the total assets of Translational Development Acquisition Corp. (TDACW)?

As of 2025, Translational Development Acquisition Corp. (TDACW) had total assets of $181.7M including $0.0M in current assets.

How much debt does Translational Development Acquisition Corp. (TDACW) have?

Translational Development Acquisition Corp. (TDACW) carries total debt of $0.2M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Translational Development Acquisition Corp.?

Translational Development Acquisition Corp. (TDACW) has total shareholders' equity (book value) of $175.1M ($10.15 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Translational Development Acquisition Corp.'s current ratio and liquidity?

Translational Development Acquisition Corp. (TDACW) reported a current ratio of 0.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.